Safinamide in Levodopa Induced Dyskinesia in Parkinson's Disease Subjects (Safinamide-LID)
-
- STATUS
- Not Recruiting
-
- participants needed
- 26
-
- sponsor
- Newron Pharmaceuticals SPA
Updated on 22 July 2024
Summary
Approximately twenty four (24) subjects will participate in this research trial. The research trial will be conducted in approximately twelve (12) medical centers in the following countries: Germany, France, South Africa, Austria and Canada. The research trial will last until December 2011.
Details
| Condition | Parkinson's Disease |
|---|---|
| Age | 30years or above |
| Treatment | Placebo, Safinamide |
| Clinical Study Identifier | NCT01113320 |
| Sponsor | Newron Pharmaceuticals SPA |
| Last Modified on | 22 July 2024 |
How understandable was the trial content above?
Hard to understand
Easy to understand
Similar trials to consider
Loading...
Not finding what you're looking for?
Sign up as a volunteer to stay informed
Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.
Sign up as volunteerStudy Definition
WikipediaAdd a private note
- Select a piece of text.
- Add notes visible only to you.
- Send it to people through a passcode protected link.